M&G Investment Management’s Acceleron Pharma XLRN Stock Holding History

M&G Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,078	Closed	-$1.04K	–	798
2021 Q3	$1.04K	Sell	6,078 -4,226	-41%	-$553K	﹤0.01%	624
2021 Q2	$1.29K	Buy	+10,304	New	+$1.3M	﹤0.01%	591

M&G Investment Management's XLRN Position: Q4 2021 in Review

M&G Investment Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,078 shares — an estimated $1.04K sold.

M&G Investment Management first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $1.29K in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

M&G Investment Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
M&G Investment Management sold 6,078 Acceleron Pharma shares in Q4 2021, an estimated $1.04K.
M&G Investment Management first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
M&G Investment Management's Acceleron Pharma position peaked at $1.29K in Q2 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.